IRIS PubliCatt

PubliCatt è il repository istituzionale ad accesso aperto dell'Università Cattolica del Sacro Cuore, dove gli utenti autorizzati afferenti all'Ateneo provvedono direttamente e autonomamente a depositare e a rendere visibili le proprie pubblicazioni, inserendo i dati descrittivi del documento stesso ("metadati", quali il titolo, autore, abstract, etc.) e, laddove possibile, il testo della pubblicazione stessa (full-text).

PubliCatt utilizza la piattaforma IRIS (Institutional Research Information System) sviluppata da CINECA.

Prodotti recenti

Digital Editions of Text: Surveying User Requirements in the Digital Humanities

This article presents the findings of a web survey designed to better understand the expectations and use of digital editions of texts. The survey, modelled upon a detailed analysis of 242 projects, recorded 218 complete responses, shedding light on user requirements of digital edi...

Tailored Ag-Cu-Mg multielemental nanoparticles for wide-spectrum antibacterial coating

Bactericidal nanoparticle coatings are very promising for hindering the indirect transmission of pathogens through cross-contaminated surfaces. The challenge, limiting their employment in nosocomial environments, is the ability of tailoring the coating's physicochemical properties, namely, composition, cytotoxicity,&...

Photoacoustic Sensing of Trapped Fluids in Nanoporous Thin Films: Device Engineering and Sensing Scheme

Accessing fluid infiltration in nanogranular coatings is an outstanding challenge, of relevance for applications ranging from nanomedicine to catalysis. A sensing platform, allowing quantifying the amount of fluid infiltrated in a nanogranular ultrathin coating, with thickness in the 10-40 nm ran...

Varro on civil war

A short commentary on Varro's fragments (in particular from his work De vita populi Romani) concerning Roman civil wars.

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis and panuveitis: a retrospective observational study of 107 patients

To compare the efficacy of adalimumab (ADA) and infliximab (IFX) in patients with non-infectious intermediate uveitis, posterior uveitis, and panuveitis. Demographic, clinical, instrumental, and therapeutic data from patients enrolled were collected at the start of treatment, at 12-month follow-up, an...